🇺🇸 FDA
Pipeline program

Rifamycin SV-MMX

CB-01-11/29

Phase 2 small_molecule active

Quick answer

Rifamycin SV-MMX for Traveler's Diarrhea is a Phase 2 program (small_molecule) at RedHill Biopharma with 2 ClinicalTrials.gov record(s).

Program details

Company
RedHill Biopharma
Indication
Traveler's Diarrhea
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials